Literature DB >> 17174802

Fluorodeoxyglucose and calcium uptake in the vascular wall: clinically relevant or sugar-coated pill?

Barry L Zaret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17174802     DOI： 10.1016/j.nuclcard.2006.09.004

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

Review 1.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

2.  Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.

Authors:  Simona Ben-Haim; Ela Kupzov; Ada Tamir; Alex Frenkel; Ora Israel
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

3.  Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography.

Authors:  S Schroeder; A F Kopp; A Baumbach; C Meisner; A Kuettner; C Georg; B Ohnesorge; C Herdeg; C D Claussen; K R Karsch
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

4.  Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins.

Authors:  A M Lees; R S Lees; F J Schoen; J L Isaacsohn; A J Fischman; K A McKusick; H W Strauss
Journal:  Arteriosclerosis       Date:  1988 Sep-Oct

5.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).

Authors:  R J Lederman; R R Raylman; S J Fisher; P V Kison; H San; E G Nabel; R L Wahl
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

6.  Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.

Authors:  S Tsimikas; W Palinski; S E Halpern; D W Yeung; L K Curtiss; J L Witztum
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

7.  Vascular cell adhesion molecule-1-targeted detection of endothelial activation in human microvasculature.

Authors:  M M Sadeghi; J S Schechner; S Krassilnikova; A A Gharaei; J Zhang; N Kirkiles-Smith; A J Sinusas; B L Zaret; J R Bender
Journal:  Transplant Proc       Date:  2004-06       Impact factor: 1.066

8.  In vivo imaging of proteolytic activity in atherosclerosis.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Umar Mahmood; Vasilis Ntziachristos; Robert Gyurko; Mark C Fishman; Paul L Huang; Ralph Weissleder
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.